Medical Condition News

RSS

Early diagnosis of colorectal cancer can minimize treatment side effects in survivors

Renato Lenzi, M.D., medical oncologist at The University of Texas MD Anderson Cancer Center and colon cancer survivor, knows only too well how important preventive methods are to beating colorectal cancer. After all, a routine colonoscopy saved his life.

24 Mar 2011

Gut bacteria and state of immune system influence personality

Researchers at McMaster University discovered that the "cross-talk" between bacteria in our gut and our brain plays an important role in the development of psychiatric illness, intestinal diseases and probably other health problems as well including obesity.

24 Mar 2011

Cardiac pacing may help epilepsy patients with seizure-related falls

Mayo Clinic researchers have found that cardiac pacing may help epilepsy patients with seizure-related falls due to ictal asystole, an unusual condition in which the heart stops beating during an epileptic seizure. The study was recently published in the journal Epilepsia.

24 Mar 2011

Fudan, UTHealth introduce international network to fight against scleroderma

Scleroderma clinicians and researchers in the United States and China have launched an international network to fight this debilitating disease that affects more than one million people worldwide.

24 Mar 2011

Oral contraceptive use before pregnancy does not pose respiratory problems in children

A new study by researchers at RTI International, the National Institute of Environmental Health Sciences, and the Norwegian Institute of Public Health refutes previous findings that oral contraceptive use before pregnancy is linked to respiratory problems in children.

24 Mar 2011

Scientists reveal protein target that can trigger myocarditis

People with type 1 diabetes, whose insulin-producing cells have been destroyed by the body's own immune system, are particularly vulnerable to a form of inflammatory heart disease caused by a different autoimmune reaction.

24 Mar 2011

Rapid treatment within an hour of injury dramatically cuts bleeding deaths in injured patients

An hour can make the difference between life and death when using tranexamic acid to treat injured patients with severe bleeding, a study by researchers at the London School of Hygiene & Tropical Medicine suggests.

24 Mar 2011

Rexahn completes 33% of 300 patient enrollment in Serdaxin Phase IIb clinical trial for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has enrolled 33 percent of the total projected patients required for its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).

24 Mar 2011

Insomnia affects 20% of the Spanish population

Insomnia is common in Spain, and affects one person in every five. This is the conclusion of a study carried out by the Vall d'Hebron University Hospital in Barcelona and the Stanford University School of Medicine (USA), which shows that 40% of survey respondents aged over 65 report interrupted sleep at night being the prime cause of this problem.

24 Mar 2011

NephRx receives new U.S. patent for NX002 to treat IBD

NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.

24 Mar 2011

Individuals who smoke mentholated cigarettes do not develop lung cancer

Individuals who smoke mentholated cigarettes are no more likely to develop lung cancer or to die from the disease than smokers of non-mentholated cigarettes, according to a new study led by William Blot, Ph.D., professor of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tenn., and colleagues at VICC, Meharry Medical College, Nashville, and the International Epidemiology Institute, Rockville, Md.

24 Mar 2011

Oramed reports successful completion of ORMD-0801 oral insulin toxicity study

Oramed Pharmaceuticals Inc., a developer of oral delivery systems, announced today that it has successfully completed a comprehensive toxicity study for its flagship oral insulin capsule, ORMD-0801.

24 Mar 2011

New research can lead to better OA treatment

Arthritis researchers from North America and Europe will convene in Chicago this week to present new osteoarthritis research that could lead to better ways to detect, treat, prevent and cure osteoarthritis, which affects 27 million Americans.

24 Mar 2011

Researchers develop new epileptic seizure-detection method

Researchers at Concordia University have pioneered a computer-based method to detect epileptic seizures as they occur - a new technique that may open a window on the brain's electrical activity.

24 Mar 2011

MicroRNAs may play a key role in future medicine

Since their discovery in the 1990s, microRNAs have proven to play a complex role in normal and abnormal functioning of many organ systems. In the April issue of Translational Research, entitled "MicroRNAs: A Potential New Frontier for Medicine," an international group of medical experts explores several themes related to our current understanding of microRNAs and the role they may play in the future of medicine.

24 Mar 2011

KaloBios commences KB004 Phase 1 trial in patients with leukemia

KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced treatment of the first patient in a Phase 1 clinical trial of KB004, its first-in-class Humaneered™ monoclonal antibody, in EphA3-expressing hematologic malignancies.

24 Mar 2011

Specific plant oil may reduce belly fat in humans

Scientists have known for years that belly fat leads to serious medical problems, including diabetes, cardiovascular disease, hypertension and stroke. Now, a University of Missouri researcher has found a plant oil that may be able to reduce belly fat in humans.

24 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

Positive data from Omeros' OMS302 Phase 2b trial in patients undergoing cataract surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.

23 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011